Home > News > Lonnie Bookbinder Selected as CEO of SpeciGen
April 26th, 2006
Lonnie Bookbinder Selected as CEO of SpeciGen
Abstract:
SpeciGen announced today the appointment of Lonnie Bookbinder, MBA, Ph.D., of Corvallis Montana, as Chief Executive Officer. Dr. Bookbinder is the first CEO of SpeciGen and brings over 35 years of bio-pharmaceutical industry and executive experience to SpeciGen, an early stage drug development company. SpeciGen is an early stage developmental biotechnology company with a focus on drug delivery using nanotechnology.
Source:
pharmalive.com
Related Links |
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Appointments/Promotions/New hires/Resignations/Deaths
Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021
JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021
The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||